Publication: Targeted nanoagents for the detection of cancers
No Thumbnail Available
Open/View Files
Date
2010
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley Open Access
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
McCarthy, Jason R., Jayeeta Bhaumik, Mark R. Karver, S. Sibel Erdem, and Ralph Weissleder. 2010. “Targeted Nanoagents for the Detection of Cancers.” Molecular Oncology 4 (6): 511–28. https://doi.org/10.1016/j.molonc.2010.08.003.
Research Data
Abstract
Nanotechnology has enabled a renaissance in the diagnosis of cancers. This is due, in part to the ability to develop agents bearing multiple functionalities, including those utilized for targeting, imaging, and therapy, allowing for the tailoring of the properties of the nanomaterials. Whereas many nanomaterials exhibit localization to diseased tissues via intrinsic targeting, the addition of targeting ligands, such as antibodies, peptides, aptamers, and small molecules, facilitates far more sensitive cancer detection. As such, this review focuses upon some of the most poignant examples of the utility of affinity ligand targeted nanoagents in the detection of cancer.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service